LINC00852

Across TCGA pan-cancer cohorts, LINC00852 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC00852 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC00852 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00852 expression acts as an unfavorable survival marker, although some lineages such as BLCA and COAD show a favorable association.

OV, BLCA, and LIHC are the cancer types where LINC00852 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Quartile	IV	0.515	0.897	.004	70	view →
BLCA	OS	Median	II,III,IV	0.763	0.649	.003	42	view →
LIHC	DFS	Quartile	All	0.200	0.422	.003	38	view →
COAD	OS	Median	III,IV	0.857	0.684	.010	32	view →
LGG	DFS	Tertile	All	0.748	0.874	<.001	30	view →
SKCM	OS	Median	IV	0.829	0.293	<.001	23	view →
THYM	OS	Tertile	II,III,IV	1.000	0.694	.005	23	view →
READ	OS	Quartile	IV	1.000	0.560	.005	20	view →
UCEC	DFS	Quartile	III,IV	0.670	0.390	.010	20	view →
ACC	DFS	Tertile	III,IV	0.080	0.414	.012	18	view →
KICH	OS	Tertile	II,III,IV	0.700	1.000	.014	18	view →
PAAD	DFS	Quartile	All	0.360	0.116	.021	17	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LINC00852–OV (OS)

Open the OV breakdown →